Xilio Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Xilio Therapeutics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2022.
  • Xilio Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000.
  • Xilio Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Xilio Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Xilio Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.